Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate Cancer

Radioimmunotherapy (RIT) has demonstrated efficacy with acceptable toxicity leading to approval in non-Hodgkin’s lymphoma, but has been slower to develop for the treatment of advanced solid tumors. Prostate cancer (PC) represents a good candidate for RIT based upon high exposure to circulating antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Tagawa, Scott T., Akhtar, Naveed H., Nikolopoulou, Anastasia, Kaur, Gurveen, Robinson, Brian, Kahn, Renee, Vallabhajosula, Shankar, Goldsmith, Stanley J., Nanus, David M., Bander, Neil H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752585/
https://www.ncbi.nlm.nih.gov/pubmed/23986881
http://dx.doi.org/10.3389/fonc.2013.00214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752585/
https://www.ncbi.nlm.nih.gov/pubmed/23986881
http://dx.doi.org/10.3389/fonc.2013.00214

Ejemplares similares